21256-18-8 | 3-(diphenyl-1,3-oxazol-2-yl)propanoic acid

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$12.00	$8.00
25g	98%	in stock	$49.00	$34.00
100g	98%	in stock	$137.00	$96.00
500g	98%	in stock	$448.00	$314.00

Description

• Catalog Number: AB63201
• Chemical Name: 3-(diphenyl-1,3-oxazol-2-yl)propanoic acid
• CAS Number: 21256-18-8
• Molecular Formula: C18H15NO3
• Molecular Weight: 293.3166
• MDL Number: MFCD00215977
• SMILES: OC(=O)CCc1nc(c(o1)c1ccccc1)c1ccccc1

Computed Properties

• Complexity: 361
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 22
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 5
• XLogP3: 4.2

Literature

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach.

  European journal of medicinal chemistry 20120701

• Genetic toxicology and toxicogenomic analysis of three cigarette smoke condensates in vitro reveals few differences among full-flavor, blonde, and light products.

  Environmental and molecular mutagenesis 20120501

• Synthesis, characterization and antiproliferative activity of transition metal complexes with 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid (oxaprozin).

  Chemical & pharmaceutical bulletin 20120101

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20110801

• Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: a toxicogenomic study.

  Environmental and molecular mutagenesis 20110701

• The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.

  Journal of biomedicine & biotechnology 20110101

• Characterization of a novel and spontaneous mouse model of inflammatory arthritis.

  Arthritis research & therapy 20110101

• A predictive ligand-based Bayesian model for human drug-induced liver injury.

  Drug metabolism and disposition: the biological fate of chemicals 20101201

• Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

  Healthcare informatics research 20101201

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Effect of ketorolac and diclofenac on the impairment of endothelium-dependent relaxation induced by reactive oxygen species in rabbit abdominal aorta.

  Korean journal of anesthesiology 20100901

• Analgesic and anti-inflammatory effects of oxaprozin and naproxen sodium after removal of impacted lower third molars: a randomized, double-blind, placebo-controlled crossover study.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501

• Theoretical and vibrational studies of 4,5-diphenyl-2-2 oxazole propionic acid (oxaprozin).

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100401

• Testing for mean and correlation changes in microarray experiments: an application for pathway analysis.

  BMC bioinformatics 20100101

• Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.

  Journal of microencapsulation 20100101

• CK1epsilon is required for breast cancers dependent on beta-catenin activity.

  PloS one 20100101

• Nonsteroidal Anti-Inflammatory Drugs: A survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data.

  Pediatric rheumatology online journal 20100101

• Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.

  Drug design, development and therapy 20100101

• Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions.

  Clinical interventions in aging 20100101

• Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases.

  BMC psychiatry 20100101

• Magnetic Fe₃O₄ nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells.

  International journal of nanomedicine 20100101

• p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells.

  PloS one 20100101

• Design, synthesis, and in-vivo evaluation of 4,5-diaryloxazole as novel nonsteroidal anti-inflammatory drug.

  Biological & pharmaceutical bulletin 20091201

• Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

  Nature chemical biology 20091001

• Delayed apoptosis of human monocytes exposed to immune complexes is reversed by oxaprozin: role of the Akt/IkappaB kinase/nuclear factor kappaB pathway.

  British journal of pharmacology 20090501

• Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways.

  Journal of biomedicine & biotechnology 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Development of a selective molecularly imprinted polymer-based solid-phase extraction for indomethacin from water samples.

  Analytical and bioanalytical chemistry 20080801

• Topical ocular delivery of NSAIDs.

  The AAPS journal 20080601

• Spread pattern of the first dengue epidemic in the city of Salvador, Brazil.

  BMC public health 20080101

• Free drug metabolic clearance in elderly people.

  Clinical pharmacokinetics 20080101

• Singlet oxygen scavenging activity of non-steroidal anti-inflammatory drugs.

  Redox report : communications in free radical research 20080101

• The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells.

  Cancer research 20070401

• In silico prediction of pregnane X receptor activators by machine learning approaches.

  Molecular pharmacology 20070101

• Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis.

  Arthritis research & therapy 20070101

• A peripatetic pediatrician's journey into pediatric rheumatology: Part II.

  Pediatric rheumatology online journal 20070101

• The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy.

  Pharmacoepidemiology and drug safety 20061201

• Studies on the interaction between Oxaprozin-E and bovine serum albumin by spectroscopic methods.

  International journal of biological macromolecules 20061115

• Effects of isopropyl palmitate on the skin permeation of drugs.

  Biological & pharmaceutical bulletin 20061101

• An exploratory theoretical elucidation on the peroxyl-radical-scavenging mechanism and structure-activity relationship of nonsteroidal anti-inflammatory drugs.

  Bioorganic & medicinal chemistry letters 20060615

• Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes.

  The Journal of pharmacy and pharmacology 20060101

• Analytic performance evaluation of a new turbidimetric immunoassay for phenytoin on the ADVIA 1650 analyzer: effect of phenytoin metabolite and analogue.

  Therapeutic drug monitoring 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• A review of the emerging profile of the anti-inflammatory drug oxaprozin.

  Expert opinion on pharmacotherapy 20050501

• Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs.

  Life sciences 20050429

• Patient characteristics associated with outpatient prescriptions for nabumetone and oxaprozin versus celecoxib and rofecoxib.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050401

• Subjective impact of osteoarthritis flare-ups on patients' quality of life.

  Health and quality of life outcomes 20050101

• In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs.

  Free radical biology & medicine 20041201

• Oxaprozin: kinetic and dynamic profile in the treatment of pain.

  Current medical research and opinion 20040801

• Oxaprozin versus diclofenac in NSAID-refractory periarthritis pain of the shoulder.

  Current medical research and opinion 20040801

• The 'high solubility' definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs.

  Pharmaceutical research 20040201

• Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin.

  Drugs & aging 20040101

• [Meta-analysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritis treated with non-steroidal anti-inflammatory drugs].

  Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 20031101

• Identification and prediction of promiscuous aggregating inhibitors among known drugs.

  Journal of medicinal chemistry 20031009

• The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.

  The Journal of rheumatology 20031001

• Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells.

  The Journal of pharmacology and experimental therapeutics 20020701

• Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

  The Journal of biological chemistry 20020419

• Pharmacological profile of oxaprozin eye drops.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20020201

• Nonsteroidal antiinflammatory drug-induced pseudoporphyria: a case series.

  Journal of cutaneous medicine and surgery 20020101

• Search of antimicrobial activity of selected non-antibiotic drugs.

  Acta poloniae pharmaceutica 20020101

• Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test.

  Journal of pharmacokinetics and pharmacodynamics 20010601

• Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care.

  Journal of the American Geriatrics Society 20010501

• A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis.

  Journal of Tongji Medical University = Tong ji yi ke da xue xue bao 20010101

• Oxaprozin-induced symptomatic hepatotoxicity.

  The Annals of pharmacotherapy 19990901

• Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells.

  European journal of pharmacology 19980417

• Oxaprozin-induced fulminant hepatitis.

  The Annals of pharmacotherapy 19941001